The medications in this class that most travelers are currently managing include: Semaglutide-based medications: Ozempic (semaglutide, weekly injection) type 2 diabetes Wegovy (semaglutide, weekly injection) chronic weight management Rybelsus (semaglutide, daily oral tablet) type 2 diabetes Tirzepatide-based medications: Mounjaro (tirzepatide, weekly injection) type 2 diabetes Zepbound (tirzepatide, weekly injection) chronic weight management Compounded formulations: Compounded semaglutide and tirzepatide widely prescribed through telehealth platforms
REDEFINE 1 (NCT05567796), REDEFINE 2 (NCT05394519), REDEFINE 3 (NCT05669755), REDEFINE 4 (NCT06131437), REDEFINE 11 (NCT07011667), REIMAGINE 2 (NCT06065540)
the specific legal entity name of the medical group crediting the providers who review Zevay intakes (Zevay's site names "Telegra MD," while Telegra MD's own materials describe itself as a facilitating platform working through separate, unnamed Provider Groups - both statements are reported here as stated by their respective sources, with the underlying credentialing entity unconfirmed)
Talk to your provider about all possible side effects while taking this medication
